The Orthopedic Implant Company (OIC) is continuing to develop its line of “high-value” orthopedic trauma implant devices with the roll-out of a new dorsal-spanning plate.
The US Food and Drug Administration cleared OIC’s DRPx distal radius plating system for the fixation of intra- and extra-articular fractures and osteotomies of the distal radius in April 2021....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?